Página principal > Resultados de la búsqueda: Balp, M.‐M.
  Consejos para la búsqueda
Búsqueda avanzada
Buscar colecciones:
Ordenar por: Mostrar resultados: Formato de visualización:

No se han encontrado coincidencias con Balp, M.‐M., pero utilizando en su lugar Balp M M ...
Resultados globales: 6 registros encontrados en 0.02 segundos.
Artículos, Encontrados 6 registros
Artículos Encontrados 6 registros  
1.
12 p, 1.1 MB Ligelizumab improves angioedema, disease severity and quality-of-life in patients with chronic spontaneous urticaria / Metz, Martin (Fraunhofer Institute for Translational Medicine and Pharmacology ITMP (Berlin, Alemanya)) ; Bernstein, Jonathan (University of Cincinnati College of Medicine and Bernstein Clinical Research Center) ; Giménez-Arnau, Ana M 1961- (Institut Hospital del Mar d'Investigacions Mèdiques) ; Hide, Michihiro (Hiroshima City Hospital) ; Maurer, Marcus (Fraunhofer Institute for Translational Medicine and Pharmacology ITMP) ; Sitz, Karl (Little Rock Allergy and Asthma Clinic) ; Soong, Weily (AllerVie Health-Alabama Allergy and Asthma Center) ; Sussman, Gordon (University of Toronto) ; Hua, Eva (Shanghai Novartis Trading Ltd) ; Barve, Avantika (Novartis Pharmaceuticals Corporation) ; Barbier, Nathalie (Novartis Pharma AG) ; Balp, Maria Magdalena (Novartis Pharma AG) ; Severin, Thomas (Novartis Pharma AG) ; Universitat Autònoma de Barcelona
Disease burden is particularly high in Chronic Spontaneous Urticaria (CSU) patients with angioedema, and patients whose signs and symptoms are inadequately controlled by H-antihistamines need new treatment options. [...]
2022 - 10.1016/j.waojou.2022.100716
The World Allergy Organization Journal, Vol. 15 (november 2022)  
Registro completo - Creative Commons
2.
11 p, 1.1 MB Ligelizumab improves sleep interference and disease burden in patients with chronic spontaneous urticaria / Giménez-Arnau, Ana M 1961- (Institut Hospital del Mar d'Investigacions Mèdiques) ; Maurer, Marcus (Charité - Universitätsmedizin Berlin. Allergie-Centrum-Charité) ; Bernstein, Jonathan (College of Medicine) ; Staubach, Petra (University Medical Center Mainz) ; Barbier, Nathalie (Novartis Pharma AG) ; Hua, Eva (China Novartis Institutes for Biomedical Research) ; Severin, Thomas (Novartis Pharma) ; Joubert, Yolandi (Novartis Pharma) ; Janocha, Reinhold (Novartis Pharma) ; Balp, Maria Magdalena (Novartis Pharma) ; Universitat Autònoma de Barcelona
Chronic spontaneous urticaria (CSU) negatively impacts patients' sleep, thereby reducing health-related quality of life (HRQoL). Half of patients with inadequately controlled CSU report sleep interference often or every night, which can lead to depression, anxiety, social, and work-related problems. [...]
2022 - 10.1002/clt2.12121
Clinical and translational allergy, Vol. 12 (february 2022)  
Registro completo - Creative Commons
3.
10 p, 954.7 KB Improvement of sleep in patients with chronic idiopathic/spontaneous urticaria treated with omalizumab : results of three randomized, double-blind, placebo-controlled studies / Giménez-Arnau, Ana M 1961- (Universitat Autònoma de Barcelona. Departament de Medicina) ; Spector, Sheldon (California Allergy and Asthma Medical Group, Inc.) ; Antonova, Evgeniya (Medical Affairs, Genentech, Inc.) ; Trzaskoma, Benjamin (Medical Affairs, Genentech, Inc.) ; Rosén, Karin (Medical Affairs, Genentech, Inc.) ; Omachi, Theodore A. (Medical Affairs, Genentech, Inc.) ; Stull, Donald (Data Analytics and Design Strategy, RTI Health Solutions, Manchester) ; Balp, Maria Magdalena (HEOR in Global Patient Access, Novartis Pharma AG) ; Murphy, Thomas (National Allergy, Asthma, and Urticaria Centers of Charleston)
Patients with chronic idiopathic/spontaneous urticaria (CIU/CSU) report difficulty with sleep. We examined the effect of omalizumab on sleep-related outcomes during 3-6 months omalizumab or placebo treatment and a 16-week follow-up period within three Phase III double-blind randomized placebo-controlled pivotal trials in CIU/CSU: ASTERIA I, ASTERIA II, and GLACIAL. [...]
2016 - 10.1186/s13601-016-0120-0
Clinical and translational allergy, Vol. 6 (august 2016)  
Registro completo - Creative Commons
4.
11 p, 1.3 MB Angioedema in chronic spontaneous urticaria is underdiagnosed and has a substantial impact : analyses from ASSURE-CSU / Sussman, Gordon (University of Toronto) ; Abuzakouk, Mohamed (Cleveland Clinic Abu Dhabi) ; Bérard, Frédéric (Claude Bernard University Lyon) ; Canonica, G. Walter (Humanitas University) ; Oude Elberink, H. (University Medical Center Groningen. University of Groningen) ; Giménez-Arnau, Ana M.. 1961- , (Universitat Autònoma de Barcelona) ; Grattan, Clive (Guy's and St Thomas' NHS Foundation Trust (Regne Unit)) ; Hollis, Kelly (RTI Health Solutions) ; Hunter, S. (RTI Health Solutions) ; Knulst, A. (University Medical Center) ; Lacour, Jean Philippe (Université Nice Sophia Antipolis) ; Lynde, Charles (Lynderm Research) ; Marsland, Alexander (University of Manchester) ; McBride, Doreen (RTI Health Solutions) ; Maurer, Marcus. (Charité - Universitätsmedizin Berlin) ; Nakonechna, A. (Royal Liverpool and Broadgreen University Hospitals) ; Ortiz de Frutos, J. (Hospital Universitario 12 de Octubre (Madrid)) ; Reynolds, M. (RTI Health Solutions) ; Sweeney, C. (RTI Health Solutions) ; Tian, H. (Novartis Pharmaceuticals Corporation) ; Weller, Karsten. (Charité - Universitätsmedizin Berlin) ; Wolin, D. (RTI Health Solutions) ; Balp, Maria Magdalena. (Novartis Pharma AG) ; Universitat Autònoma de Barcelona
ASSURE-CSU revealed differences in physician and patient reporting of angioedema. This post hoc analysis was conducted to evaluate the actual rate of angioedema in the study population and explore differences between patients with and without angioedema. [...]
2018 - 10.1111/all.13430
Allergy, Vol. 73 (july 2018) , p. 1724-1734  
Registro completo - Creative Commons
5.
12 p, 716.3 KB The burden of chronic spontaneous urticaria is substantial : real-world evidence from ASSURE-CSU / Maurer, Marcus (Charité - Universitätsmedizin Berlin) ; Abuzakouk, Mohamed (Cleveland Clinic Abu Dhabi) ; Bérard, Frédéric (Université Claude Bernard Lyon 1) ; Canonica, G. Walter (IRCCS Istituto Clinico Humanitas) ; Oude Elberink, H. (Rijksuniversiteit Groningen) ; Giménez-Arnau, Ana M.. 1961- (Parc de Salut MAR de Barcelona) ; Grattan, Clive (Guy's and St Thomas' NHS Foundation Trust (Regne Unit)) ; Hollis, Kelly (RTI Health Solutions) ; Knulst, A. (Universitair Medisch Centrum Utrecht) ; Lacour, Jean Philippe (Université Nice Sophia Antipolis) ; Lynde, Charles (Lynderm Research) ; Marsland, Alexander (Salford Royal Hospital) ; McBride, Doreen (RTI Health Solutions) ; Nakonechna, Alla (The Royal Liverpool University Hospita) ; Ortiz de Frutos, Javier (Hospital Universitario 12 de Octubre (Madrid)) ; Proctor, Christina (RTI Health Solutions) ; Sussman, Gordon (University of Toronto) ; Sweeney, Carolyn (RTI Health Solutions) ; Tian, Haijun (Novartis Pharmaceuticals Corporation) ; Weller, Karsten (Charité - Universitätsmedizin Berlin) ; Wolin, Daniel (RTI Health Solutions) ; Balp, Maria Magdalena (Novartis Pharma AG) ; Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia
Chronic spontaneous urticaria () can be debilitating, difficult to treat, and frustrating for patients and physicians. Real-world evidence for the burden of is limited. The objective of this study was to document disease duration, treatment history, and disease activity, as well as impact on health-related quality of life (oL) and work among patients with inadequately controlled , and to describe its humanistic, societal, and economic burden. [...]
2017 - 10.1111/all.13209
Allergy, Vol. 72, issue 12 (Dec. 2017) , p. 2005-2016  
Registro completo - Creative Commons
6.
7 p, 798.5 KB ASSURE-CSU : a real-world study of burden of disease in patients with symptomatic chronic spontaneous urticaria / Weller, Karsten (Allergie-Centrum-Charité) ; Maurer, Marcus (Allergie-Centrum-Charité) ; Grattan, Clive (Norfolk and Norwich University Hospital) ; Nakonechna, Alla (Royal Liverpool and Broadgreen University Hospital) ; Abuzakouk, Mohamed (Royal Liverpool and Broadgreen University Hospital) ; Bérard, Frédéric (Claude Bernard University Lyon I) ; Sussman, Gordon (Gordon Sussman Clinical Research Inc) ; Giménez-Arnau, Ana M.. 1961- (Hospital del Mar (Barcelona, Catalunya)) ; Ortiz de Frutos, Javier (Hospital Universitario 12 de Octubre (Madrid)) ; Knulst, André (UMC) ; Canonica, G. Walter (University of Genoa) ; Hollis, Kelly (RTI Health Solutions) ; McBride, Doreen (RTI Health Solutions) ; Balp, Maria Magdalena (Novartis Pharma AG) ; Universitat Autònoma de Barcelona. Departament de Medicina
Chronic spontaneous urticaria (CSU) formerly known as chronic idiopathic urticaria (CIU) is a severe and distressing skin condition that remains uncontrolled in approximately one half of patients, despite the use of licensed, recommended doses of modern, second-generation H-antihistamines. [...]
2015 - 10.1186/s13601-015-0072-9
Clinical and translational allergy, Vol. 5 (august 2015)  
Registro completo - Creative Commons

Vea también: autores con nombres similares
5 Balp, Maria Magdalena
1 Balp, Maria Magdalena.
¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.
Depósito Digital de Documentos de la UAB :: Buscar :: Enviar :: Personalizar :: Ayuda
Powered by Invenio v1.1.6
Mantenido por ddd.bib@uab.cat  :: Metadatos sujetos a:
Colaboramos